顺铂、持续输注长春地辛和5-氟尿嘧啶治疗非小细胞肺癌（ATTIT 002）。ATTIT（胸内肿瘤治疗协会）。 - Suppr | 超能文献

Cisplatin and continuous infusion vindesine and 5-fluorouracil in non-small cell lung cancer (NSCLC) (ATTIT 002). ATTIT (Association pour le Traitment des Tumeurs Intra-Thoraciques).

作者信息

Riggi M, Cvitkovic E, de Cremoux H, Ruffie P, Monnet I, Voisin S, Villalobos W, Azli N, Saltiel J C

出版信息

Eur J Cancer. 1993;29A(13):1914-5. doi: 10.1016/0959-8049(93)90558-w.

DOI:10.1016/0959-8049(93)90558-w

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Cisplatin and continuous infusion vindesine and 5-fluorouracil in non-small cell lung cancer (NSCLC) (ATTIT 002). ATTIT (Association pour le Traitment des Tumeurs Intra-Thoraciques).顺铂、持续输注长春地辛和5-氟尿嘧啶治疗非小细胞肺癌（ATTIT 002）。ATTIT（胸内肿瘤治疗协会）。

Eur J Cancer. 1993;29A(13):1914-5. doi: 10.1016/0959-8049(93)90558-w.

2

Influence of pretreatment clinical characteristics on the response rate to mitomycin/vindesine/cisplatin (MVP) in unresectable non-small cell lung cancer. ATTIT (Association pour le Traitement des Tumeurs Intra-Thoraciques).

Eur J Cancer. 1991;27(10):1238-42. doi: 10.1016/0277-5379(91)90089-v.

3

Cisplatin-based chemotherapy for postoperative recurrence in non-small cell lung cancer patients: relation of the in vitro chemosensitive test to clinical response.

Oncol Rep. 2001 Mar-Apr;8(2):279-83. doi: 10.3892/or.8.2.279.

4

[Pilot study of a continuous five-day intravenous infusion of cisplatin plus vindesine in advanced non-small cell lung cancer].顺铂加长春地辛连续五日静脉输注治疗晚期非小细胞肺癌的初步研究

Gan To Kagaku Ryoho. 1989 Jul;16(7):2465-8.

5

Bolus versus 5-day continuous infusion of cisplatin with mitomycin and vindesine in the treatment of advanced non-small cell lung cancer (NSCLC): a phase III prospective randomised trial of the Italian Oncology Group for Clinical Research (GOIRC).顺铂大剂量推注与5天持续输注联合丝裂霉素和长春地辛治疗晚期非小细胞肺癌（NSCLC）：意大利临床研究肿瘤学组（GOIRC）的一项III期前瞻性随机试验

Eur J Cancer. 1998 Nov;34(12):1974-6. doi: 10.1016/s0959-8049(98)00231-7.

6

[Effect of the pulmonary artery infusion chemotherapy of non-small cel lung cancer].[非小细胞肺癌肺动脉灌注化疗的疗效]

Gan To Kagaku Ryoho. 1989 Jul;16(7):2469-72.

7

Cisplatin-mitomycin and vindesine in the treatment of inoperable non-small cell lung cancer groupe français de pneumo-cancérologie (GFPC).顺铂-丝裂霉素与长春地辛治疗无法手术的非小细胞肺癌法国肺癌研究组（GFPC）

Eur J Cancer. 1993;29A(3):477. doi: 10.1016/0959-8049(93)90410-h.

8

Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC). ATTIT. Association pour le Traitement des Tumeurs Intra Thoraciques.

Eur J Cancer. 1998 Jun;34(7):1124-7. doi: 10.1016/s0959-8049(98)00007-0.

9

Combined chemotherapy and differentiation therapy in the treatment of advanced non-small-cell lung cancer.联合化疗与分化疗法治疗晚期非小细胞肺癌

Anticancer Res. 1997 Sep-Oct;17(5B):3761-5.

10

A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.长春瑞滨（诺维本）联合顺铂、长春地辛联合顺铂以及长春瑞滨单药治疗非小细胞肺癌的三臂试验：一项扩展分析。

Semin Oncol. 1994 Oct;21(5 Suppl 10):28-33; discussion 33-4.